A three-judge panel on the 5th U.S. Circuit Court of Appeals sided with Louisiana in a lawsuit against the Food and Drug Administration (FDA). The court issued a temporary nationwide injunction that reinstates a 2021 nationwide requirement that mifepristone must be prescribed and dispensed in person.
Mifepristone is one of the two drugs commonly used in medication abortions.
The FDA permanently lifted the in-person requirement in 2023, leading to a surge in pills prescribed over the internet in the wake of the Dobbs ruling that overturned the constitutional right to an abortion.
Flanked by top health officials including Health Secretary Robert F. Kennedy Jr., President Trump unveiled a...
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable...
"Do you even looksmaxx, bro?"If you've been online over the past year, odds are, you've come...
